Davis S, Schaller J, Wedgwood R, Harvard M. Job’s syndrome: recurrent," cold", staphylococcal abscesses. The Lancet. 1966;287(7445):1013–5.

Article  Google Scholar 

Yong PF, Freeman AF, Engelhardt KR, Holland S, Puck JM, Grimbacher B. An update on the hyper-IgE syndromes. Arthritis Res Ther. 2012;14:1–10.

Article  Google Scholar 

Saikia B, Rawat A, Minz RW, Suri D, Pandiarajan V, Jindal A, et al. Clinical profile of hyper-IgE syndrome in India. Front Immunol. 2021;12:626593.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chu EY, Freeman AF, Jing H, Cowen EW, Davis J, Su HC, et al. Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol. 2012;148(1):79–84.

Article  CAS  PubMed  Google Scholar 

Gharehzadehshirazi A, Amini A, Rezaei N. Hyper IgE syndromes: a clinical approach. Clin Immunol. 2022;237: 108988.

Article  CAS  PubMed  Google Scholar 

Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42(7):1508–20.

Article  PubMed  Google Scholar 

Minegishi Y. Hyper-IgE syndrome, 2021 update. Allergol Int. 2021;70(4):407–14.

Article  CAS  PubMed  Google Scholar 

Winslow A, Jalazo ER, Evans A, Winstead M, Moran T. A de novo cause of PGM3 deficiency treated with hematopoietic stem cell transplantation. J Clin Immunol. 2022;42(3):691–4.

Article  PubMed  PubMed Central  Google Scholar 

Grimbacher B, Holland SM, Puck JM. Hyper-IgE syndromes. Immunol Rev. 2005;203(1):244–50.

Article  CAS  PubMed  Google Scholar 

Ravichandran N, Uppuluri R, Swaminathan VV, Ramanan KM, Meena S, Varla H, et al. Management of peripheral T-cell lymphoma in children and adolescents including STAT 3 mutation hyper-IgE syndrome: one size does not fit all. J of Pediatr Hematol/Oncol. 2022;44(4):e849–e54.

Al Shekaili L, Sheikh F, Al Gazlan S, Al Dhekri H, Al Mousa H, Al Ghonaium A, et al. Novel mutation in DOCK8- HIES with severe phenotype and successful transplantation. Clin Immunol. 2017;178:39–44.

Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections—an autosomal dominant multisystem disorder. N Engl J Med. 1999;170(3):319–333.

Google Scholar 

Moin M, Farhoudi A, Movahedi M, Rezaei N, Pourpak Z, Yeganeh M, et al. The clinical and laboratory survey of Iranian patients with hyper-IgE syndrome. Scand J Infect Dis. 2006;38(10):898–903.

Article  PubMed  Google Scholar 

Jiao H, Tóth B, Erdős M, Fransson I, Rákóczi É, Balogh I, et al. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. Mol Immunol. 2008;46(1):202–6.

Article  CAS  PubMed  Google Scholar 

Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124(6):1289-302. e4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361(21):2046–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chandesris M-O, Melki I, Natividad A, Puel A, Fieschi C, Yun L, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine. 2012;91(4):e1–19.

Article  CAS  PubMed  Google Scholar 

Al-Herz W, Ragupathy R, Massaad MJ, Nanda A, Engelhardt KR, Grimbacher B, et al. Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait. Clin Immunol. 2012;143(3):266–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanal O, Jing H, Ozgur T, Ayvaz D, Strauss-Albee DM, Ersoy-Evans S, et al. Additional diverse findings expand the clinical presentation of DOCK8 deficiency. J Clin Immunol. 2012;32:698–708.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alsum Z, Hawwari A, Alsmadi O, Al-Hissi S, Borrero E, Abu-staiteh A, et al. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty five patients. J Clin Immunol. 2013;33:55–67.

Article  CAS  PubMed  Google Scholar 

Wolach O, Kuijpers T, Ben-Ari J, Gavrieli R, Feinstein-Goren N, Alders M, et al. Variable clinical expressivity of STAT3 mutation in hyperimmunoglobulin E syndrome: genetic and clinical studies of six patients. J Clin Immunol. 2014;34:163–70.

Article  CAS  PubMed  Google Scholar 

Aydin SE, Kilic SS, Aytekin C, Kumar A, Porras O, Kainulainen L, et al. DOCK8 deficiency: clinical and immunological phenotype and treatment options-a review of 136 patients. J Clin Immunol. 2015;35:189–98.

Article  CAS  PubMed  Google Scholar 

Engelhardt KR, Gertz ME, Keles S, Schäffer AA, Sigmund EC, Glocker C, et al. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2015;136(2):402–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abolhassani H, Chou J, Bainter W, Platt CD, Tavassoli M, Momen T, et al. Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency. J Allergy Clin Immunol. 2018;141(4):1450–8.

Article  CAS  PubMed  Google Scholar 

Gernez Y, Freeman AF, Holland SM, Garabedian E, Patel NC, Puck JM, et al. Autosomal dominant hyper-IgE syndrome in the USIDNET registry. J Allergy Clin Immunol Pract. 2018;6(3):996–1001.

Article  PubMed  Google Scholar 

Jacob M, Bin Khalaf D, Alhissi S, Arnout R, Alsaud B, Al-Mousa H, et al. Quantitative profiling of cytokines and chemokines in DOCK 8-deficient and atopic dermatitis patients. Allergy. 2019;74(2):370–9.

Article  CAS  PubMed  Google Scholar 

Tavassoli M, Abolhassani H, Yazdani R, Ghadami M, Azizi G, Abdolrahim Poor Heravi S, et al. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: a long‐term follow‐up and genetic analysis. Pediatric Allergy Immunol 30(4):469–78

Article  Google Scholar 

Maffeis M, Notarangelo LD, Schumacher RF, Soncini E, Soresina A, Lanfranchi A, et al. Primary immunodeficiencies and oncological risk: the experience of the Children’s Hospital of Brescia. Front Pediatr. 2019;7:232.

Article  PubMed  PubMed Central  Google Scholar 

Kasap N, Celik V, Isik S, Cennetoglu P, Kiykim A, Eltan SB, et al. A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis. Clin Immunol. 2021;223:108645.

Article  CAS  PubMed  Google Scholar 

Frede N, Rojas-Restrepo J, Caballero Garcia de Oteyza A, Buchta M, Hübscher K, Gámez-Díaz L, et al. Genetic analysis of a cohort of 275 patients with hyper-IgE syndromes and/or chronic mucocutaneous candidiasis. J Clin Immunol. 2021;41(8):1804–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Urban A, Wyndham NLPCMCRMW, Pittaluga S, Irini CWPCTHDNP, Freeman AF. Malignancy in STAT3 deficient hyper IgE syndrome. J Clin Immunol. 2022;42(3):699–702.

Article  CAS  PubMed  Google Scholar 

Pietzsch L, Körholz J, Boschann F, Sergon M, Dorjbal B, Yee D, et al. Hyper-IgE and carcinoma in CADINS disease. Front Immunol. 2022;13:878989.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Urdinez L, Erra L, Palma AM, Mercogliano MF, Fernandez JB, Prieto E, et al. Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: a single center experience. Front Immunol. 2022;13:1020927.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aliyath A, Eni-Olotu A, Donaldson N, Trivedi P. Malignancy-associated immune responses: lessons from human inborn errors of immunity. Immunology. 2023.

Avalle L, Camporeale A, Camperi A, Poli V. STAT3 in cancer: a double edged sword. Cytokine. 2017;98:42–50.

Article  CAS  PubMed  Google Scholar 

Su HC, Jing H, Zhang Q. DOCK8 deficiency. Ann NY Acad Sci. 2011;1246(1):26–33.

Article  CAS  PubMed  Google Scholar 

Oikonomopoulou C, Goussetis E. Autosomal dominant hyper-IgE syndrome: when hematopoietic stem cell transplantation should be considered? Pediatr Transpl. 2020;24(5):e13699.

Article  CAS  Google Scholar 

Chandesris MO, Melki I, Natividad A, Puel A, Fieschi C, Yun L, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine (Baltimore). 2012;91(4):e1–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leonard G, Posadas E, Herrmann P, Anderson V, Jaffe E, Holland S, et al. Non-Hodgkin’s lymphoma in Job’s syndrome: a case report and literature review. Leuk Lymphoma. 2004;45(12):2521–5.

Article